Found: 8
Select item for more details and to access through your institution.
Posaconazole: A Pharmacoeconomic Review of its Use in the Prophylaxis of Invasive Fungal Disease in Immunocompromised Hosts.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 3, p. 251, doi. 10.2165/11206800-000000000-00000
- By:
- Publication type:
- Article
Comparing Methods of Data Synthesis: Re-Estimating Parameters of an Existing Probabilistic Cost-Effectiveness Model.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 3, p. 239, doi. 10.2165/11539870-000000000-00000
- By:
- Publication type:
- Article
Value of Information in the Osteoarthritis Setting: Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 3, p. 225, doi. 10.2165/11584200-000000000-00000
- By:
- Publication type:
- Article
Advances in Cancer Therapeutics and Patient Access to New Drugs.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 3, p. 213, doi. 10.2165/11584210-000000000-00000
- By:
- Publication type:
- Article
Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children: A Review.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 3, p. 199, doi. 10.2165/11584930-000000000-00000
- By:
- Publication type:
- Article
Sample Size and Power for Cost-Effectiveness Analysis (Part 1).
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 3, p. 189, doi. 10.2165/11585070-000000000-00000
- By:
- Publication type:
- Article
Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 3, p. 175, doi. 10.2165/11586130-000000000-00000
- By:
- Publication type:
- Article
Including Indirect Medical Care Costs from Survivor Years of Life in Economic Evaluations.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 3, p. 173, doi. 10.2165/11588790-000000000-00000
- By:
- Publication type:
- Article